Zenith Health

17
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE812B01026
  • NSEID:
  • BSEID: 530665
INR
3.37
-0.11 (-3.16%)
BSENSE

Feb 06

BSE+NSE Vol: 18.4 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -21.72% vs 10.23% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -61.07% vs 695.62% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -12.41% vs 87.67% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -67.08% vs 161.57% in Mar 2024

Compare Profit and Loss Results of Zenith Health
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
11.00
82.00
-71.00
-86.59%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
11.00
82.00
-71.00
-86.59%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-6.00
6.00
100.00%
Raw Materials Consumed
5.00
81.00
-76.00
-93.83%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
1.00
2.00
-1.00
-50.00%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
1.00
0.00
1.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
11.00
80.00
-69.00
-86.25%
Operating Profit (PBDIT) excl Other Income
0.00
2.00
-2.00
-100.00%
Other Income
0.00
2.00
-2.00
-100.00%
Operating Profit (PBDIT)
0.00
5.00
-5.00
-100.00%
Interest
0.00
1.00
-1.00
-100.00%
Profit before Depriciation and Tax
0.00
3.00
-3.00
-100.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
0.00
3.00
-3.00
-100.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
3.00
-3.00
-100.00%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
0.00
3.00
-3.00
-100.00%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
1.00
2.00
-1.00
-50.00%
Profit Available for appropriations
2.00
6.00
-4.00
-66.67%
Appropriations
2.00
6.00
-4.00
-66.67%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.013
1.75
-1.74
-99.26%
Profit And Loss - Net Sales
Net Sales 11.33 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -21.72% vs 10.23% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.09 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -61.07% vs 695.62% in Mar 2024

Profit And Loss - Interest
Interest 0.01 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -12.41% vs 87.67% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 0.07 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -67.08% vs 161.57% in Mar 2024